Search Result "gefitinib"
Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters
Journal: Current Drug Delivery
Volume: 14 Issue: 2 Year: 2017 Page: 282-288
Author(s): Can Zhao,Shu-Yan Han,Ping-Ping Li
Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes
Journal: Drug Metabolism Letters
Volume: 7 Issue: 2 Year: 2013 Page: 126-136
Author(s): Prashant Surve,Selvan Ravindran,Arghya Acharjee,Himanshu Rastogi,Sudipta Basu,Pradnya Honrao
Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer MouseModel
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 3 Year: 2024 Page: 308-315
Author(s):
Prospective Study of the Treatment of Biotin in Patients with Drug Erythema due to Gefitinib or Erlotinib
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Yoshikazu Ogawa,Takayoshi Kiba,Kikuo Nakano,Sayoko Kajiume,Yuko Okada,Yasunori Ichiba
Doi: 10.2174/9781681080239117010040
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 5 Year: 2014 Page: 646-650
Author(s): Antonio Passaro, Daniele Alesini, Alessia Pochesci, Enrico Cortesi
Gefitinib: An Updated Review of its Role in the Cancer Management, itsNanotechnological Interventions, Recent Patents and Clinical Trials
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 448-469
Author(s):
Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 12 Year: 2016 Page: 1665-1672
Author(s): Jing-Kun Fang,Zhimin Xu,Yingjun Zhang,Weihong Zhang,Bing Liu,Yu Fang,Tengxiao Sun
Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 176-191
Author(s): R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio, M. Casto
Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 4 Year: 2017 Page: 376-385
Author(s): Ruzhen Zheng,Hao Jiang,Jinhui Li,Xinge Liu,Hongwei Xu
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 796-806
Author(s): Yufeng Wu,Zhen He,Shaomei Li,Hong Tang,Lili Wang,Sen Yang,Bing Dong,Jianjun Qin,Yue Sun,Han Yu,Yu Zhang,Yi Zhang,Yongjun Guo,Qiming Wang